TL;DR
These five are negligible in size on this book and yet the least damaged on it — and the reason is not the software sector, it is that none of them carries leverage.
- The five hold
$10.68Mbetween them, 0.8% of the book, and do$7.30Mof volume, also 0.8%. SPYB alone ($19.08M) is 1.79 times their combined size. - All five rank in the best 27 of 100 on 30-day change: ADBEB
+4.39%(11th), CRMB−1.12%(19th), PLTRB−2.02%(22nd), CRWDB−5.92%(26th), ORCLB−6.52%(27th). The group median of−2.02%is 14.69 points better than the book median of−16.71%. - Turnover, however, is exactly average:
0.6832xfor the group,0.6624xfor the other 95,0.6625xfor the book. So this is not "nobody trades it", it is "nobody parks capital in it" — two different things. - The counter-example is in the listing cohort. ORCLB has the best 30-day change of the ten names listed its day, but six of those ten are leveraged ETFs, down between
22.36%and78.03%. Topping that cohort says mostly that it is unleveraged. - Of the 18 instruments up over 30 days, the top two are −3x inverse ETFs (SOXSB
+70.82%, SQQQB+24.94%), and this group places exactly one (ADBEB, 11th). What actually made money this month was short exposure; software merely avoided the hit. - Turnover inside the group spans 12.7x: CRWDB
2.322x(15th on the book) against CRMB0.183x(97th). CRMB does$91.8Ka day, second-lowest on the book. - This snapshot cannot produce a premium. No underlying reference price, no dividend-reinvestment multiplier.
1. What these five are
bStocks is the in-house tokenized-equity issuer of Binance (BTech Holdings Limited, ADGM / FSRA listed certificates, BNB Chain only, traded on Binance only). CoinMarketCap reports 105 instruments; the snapshot behind this piece holds 100 of them, timestamped 2026-10-31T06:06:52Z.
Of those 100, only 7 carry a market cap above $50M and 12 above $25M, while 61 sit below $5M and 33 below $1M, median $2.39M.
| Token | Underlying | Listed | Days | Price | Market cap | 24h volume | Turnover | 30d |
|---|---|---|---|---|---|---|---|---|
| ORCLB | Oracle | 2026-07-20 | 103 | $130.87 | $5.72M | $2.63M | 0.460x | −6.52% |
| PLTRB | Palantir | 2026-07-02 | 121 | $184.58 | $2.77M | $2.35M | 0.848x | −2.02% |
| ADBEB | Adobe | 2026-09-29 | 32 | $249.22 | $962.2K | $538.0K | 0.559x | +4.39% |
| CRWDB | CrowdStrike | 2026-09-01 | 60 | $250.81 | $727.1K | $1.69M | 2.322x | −5.92% |
| CRMB | Salesforce | 2026-09-08 | 53 | $227.31 | $501.9K | $91.8K | 0.183x | −1.12% |
All five underlyings are enterprise software companies: databases and cloud, a data-analytics platform, creative and document software, endpoint security, customer relationship management. On this book they hold $10.68M between them, 0.8% of the book total of $1,318.38M, and do $7.30M of volume, 0.8% of the book total of $873.46M.
2. 0.8% of the book
Put that 0.8% against some concrete references:
| Reference | Market cap | This group is |
|---|---|---|
| These five combined | $10.68M | — |
| SPYB, one instrument | $19.08M | 56% of it |
| GOOGLB, one instrument | $104.99M | 10.2% of it |
| SPCXB, largest on the book | $173.96M | 6.1% of it |
| All 100 instruments | $1,318.38M | 0.8% of it |
Five enterprise-software instruments together are 56% of one S&P 500 ETF. One by one it is the same picture: ORCLB ranks 35th by market cap, PLTRB 47th, ADBEB 71st, CRWDB 81st, CRMB 91st — three of the five sit in the bottom third of the book.
Corroboration sits in other groups: MSFTB carries $4.37M and METAB $7.46M — the other large enterprise-software names on this book are the same order of magnitude.
But "small" on its own says nothing about demand, because listing date and size are tightly linked here:
| Listing month | Instruments | Market cap |
|---|---|---|
| 2026-06 | 10 | $689.03M |
| 2026-07 | 46 | $524.74M |
| 2026-08 | 12 | $38.57M |
| 2026-09 | 17 | $54.71M |
| 2026-10 | 15 | $11.34M |
Three of these five listed in 2026-09 or later, and the 32 instruments listed across 2026-09 and 2026-10 hold $66.05M in total, less than a tenth of what the 10 instruments from 2026-06 hold. Controlling for cohort, their market-cap ranks inside their own listing day are ORCLB 5th of 10, PLTRB 5th of 5, ADBEB 2nd of 5, CRWDB 4th of 4, CRMB 2nd of 2 — three at the bottom, one in the middle, one near the top. Small is real, but not as pointed as "singled out and ignored".
3. All five in the best 27 on 30 days
Of the 100 instruments, 82 are negative over 30 days, median −16.71%, 46 down more than 20% and 26 down more than 30%. All five here rank in the best 27, and not one of them is down as much as 10%.
| Token | 30d | Book rank | 7d | 24h | From high | Position in range |
|---|---|---|---|---|---|---|
| ADBEB | +4.39% | 11 | −5.15% | +0.15% | −8.3% | 49.1% |
| CRMB | −1.12% | 19 | −8.17% | −0.79% | −13.1% | 16.2% |
| PLTRB | −2.02% | 22 | −6.50% | −4.47% | −12.9% | 71.8% |
| CRWDB | −5.92% | 26 | −2.08% | −2.61% | −12.2% | 58.7% |
| ORCLB | −6.52% | 27 | +3.81% | −2.25% | −22.1% | 30.7% |
All five sit between −8.3% and −22.1% from their highs, against a book median of −27.1% and 43 instruments below −30%. Position in range says the same: the book median is 22.4%, and three of these five are above 49%.
Checked cohort by cohort, the direction holds:
| Token | Listing cohort | Rank on 30d inside it | Worst in that cohort |
|---|---|---|---|
| ORCLB | 2026-07-20 (10 names) | 1st | INTWB −78.03% |
| CRMB | 2026-09-08 (2 names) | 1st | HIMSB −8.58% |
| ADBEB | 2026-09-29 (5 names) | 2nd | SHAZB −58.17% |
| PLTRB | 2026-07-02 (5 names) | 2nd | METAB −16.00% |
| CRWDB | 2026-09-01 (4 names) | 3rd | STXB −30.40% |
Two firsts, two seconds, one third. This is not an artifact of comparing across cohorts — against control groups that listed the same day with identical windows, all five are in the upper half.
4. Counter-example: first place because there is no leverage
Those rankings invite the reading "enterprise software held up". Lay out the ORCLB cohort and that explanation collapses.
Ten instruments listed on 2026-07-20, window 103 days for all of them:
| Token | Type | 30d | Range width |
|---|---|---|---|
| ORCLB | common stock | −6.52% | 1.470x |
| TQQQB | leveraged ETF 3x | −22.36% | 1.512x |
| QNTB | unclassified | −30.51% | 2.249x |
| AXTIB | common stock | −31.51% | 2.658x |
| MUUB | leveraged ETF 2x | −33.44% | 2.223x |
| CRWVB | common stock | −38.18% | 2.274x |
| KORUB | leveraged ETF 3x | −49.66% | 2.669x |
| MVLLB | leveraged ETF 2x | −51.66% | 3.075x |
| SNXXB | leveraged ETF 2x | −61.18% | 3.243x |
| INTWB | leveraged ETF 2x | −78.03% | 5.583x |
Six of those ten are leveraged ETFs, down between 22.36% and 78.03%. ORCLB topping that cohort says first that it is unleveraged and only then anything else. The two other common stocks in the same cohort, AXTIB at −31.51% and CRWVB at −38.18%, kill "common stock held up" even more directly — they carry no leverage either and fell further than four of the leveraged ETFs.
The second counter-example is in the column marked "who actually made money". All 18 instruments up over 30 days, best first:
| Token | 30d | Type |
|---|---|---|
| SOXSB | +70.82% | inverse ETF −3x |
| SQQQB | +24.94% | inverse ETF −3x |
| LLYB | +21.31% | common stock |
| UVXYB | +20.12% | leveraged ETF 2x |
| IBMB | +16.51% | common stock |
| MRNAB | +15.34% | common stock |
| WENB | +12.62% | common stock |
| TSLAB | +11.78% | common stock |
| PYPLB | +7.49% | common stock |
| TMFB | +4.81% | leveraged ETF 3x |
| ADBEB | +4.39% | common stock |
The two largest positive returns this month belong to instruments that short an index. This group places exactly one name on that list, ADBEB at 11th — "fell less" and "made money" are two different things on this book, and this group is the former.
The third counter-example is the most direct: a group 4.2 times larger did better. Put the cold half of the Mag7 (AAPLB / MSFTB / AMZNB / METAB / TSLAB) alongside:
| Group | Market cap | Volume | Turnover | Median 30d |
|---|---|---|---|---|
| Software and SaaS (this group) | $10.68M | $7.30M | 0.6832x | −2.02% |
| Cold half of the Mag7 | $44.69M | $34.92M | 0.7812x | +1.70% |
| Whole book | $1,318.38M | $873.46M | 0.6625x | −16.71% |
It holds 4.2 times the market cap and has a better 30-day median. So "small therefore spared" does not read as cause and effect. What does hold is plainer: unleveraged, with an underlying outside the eye of this particular storm, means a shallower fall — and size has nothing to do with it.
5. Turnover is average; market cap is not
The easiest misreading of this group is treating "small market cap" as "thinly traded". On this book they are not the same thing:
| Group | Market cap | Volume | Turnover |
|---|---|---|---|
| These five | $10.68M (0.8%) | $7.30M (0.8%) | 0.6832x |
| The other 95 | $1,307.70M | $866.17M | 0.6624x |
| Whole book | $1,318.38M | $873.46M | 0.6625x |
The ratio between this group and the other 95 is 0.97 — no difference at all. Market-cap share is 0.8% and volume share is 0.8%; the two columns line up exactly. These five are not sitting untouched, they are traded normally for their size.
Inside the group, though, the spread is enormous:
| Token | Market cap | Cap rank | 24h volume | Volume rank | Turnover | Turnover rank |
|---|---|---|---|---|---|---|
| CRWDB | $727.1K | 81 | $1.69M | 65 | 2.322x | 15 |
| PLTRB | $2.77M | 47 | $2.35M | 47 | 0.848x | 52 |
| ADBEB | $962.2K | 71 | $538.0K | 91 | 0.559x | 66 |
| ORCLB | $5.72M | 35 | $2.63M | 44 | 0.460x | 74 |
| CRMB | $501.9K | 91 | $91.8K | 99 | 0.183x | 97 |
CRWDB turns over 12.7 times faster than CRMB while their market caps differ by only 1.45 times. CRWDB does $1.69M on a $727.1K cap, 15th on the book by turnover; CRMB does $91.8K a day, second-lowest on the book — the lowest is TMFB in another group at $91.6K, a gap of $200.
A note on the measure: turnover is 24h volume divided by market cap, so a small denominator inflates it — which is exactly what the second piece, the denominator trap, took apart. Half of the 2.322x at CRWDB is the $727.1K market cap underneath it, so do not read it as "CRWDB is the most liquid name in this group" — the largest absolute volume belongs to ORCLB at $2.63M, and its turnover ranks only 74th on the book.
6. Structure: what these five tokens actually are
All of it from the issuer record on this site, none of it invented:
- The wrapper is a tracker certificate, issued by BTech Holdings Limited as an ADGM / FSRA listed certificate — not equity.
- No voting rights.
- Dividends are pass-through: a 30% US withholding deduction first, then reinvested through a multiplier. This is what drives the first point in section 8.
- Reserves are covered by attestation, not an on-chain proof of reserve. Among peers, xStocks uses Chainlink proof of reserve, updated daily or on a 10% move, verifiable on chain; an attestation is not.
- Redemption is available, requires KYC, minimum $5. (Primary redemption at xStocks has a $5,000 minimum.)
- US persons are blocked.
- BNB Chain only, Binance only, BSC deposits only — a wrong-network transfer loses the asset.
- The issuance model is exchange-self: the issuer and the only trading venue are the same entity.
This is the structurally most uniform of these groups: all five underlyings are US-listed common shares — no ETF, no ADR, no leveraged product, no private company. That is worth stating on its own, because it is exactly where the conclusion of section 4 comes from: half of this group holding up is a structural property, not a sector property. The book holds 67 common stocks, 10 leveraged ETFs, 8 unclassified, 6 ADRs, 6 ETFs, 2 inverse ETFs and 1 private company, and all five of these fall in the first bucket.
No voting rights has a very concrete meaning for these particular underlyings. Governance fights at these five companies — dilution, dual-class structures, takeover offers — get settled by shareholder votes in public markets, and these tokens appear in none of them. That is not an accusation, it is the definition of the wrapper.
7. This snapshot was taken on a Saturday
The timestamp 2026-10-31T06:06:52Z is a Saturday morning UTC. The US cash market closed at 20:00 UTC on Friday and does not open again until Monday.
This has already been quantified once on the same issuer: one stock, four order books lined up four tokenized versions of AAPL on a Saturday and concluded that a quote outside trading hours is a market maker opinion, not a market price.
So read the 24-hour changes accordingly: that window (Friday 06:06 UTC to Saturday 06:06 UTC) contains a full Friday US session, so it is not a pure closed-market quote; but the snapshot itself lands inside the closure, and for the two-plus days until Monday, these token prices are the only prices these names have.
This matters more than usual for this group, because all five 24-hour changes are small (+0.15% to −4.47%). On an instrument doing $91.8K a day, "barely moved" and "barely quoted" look identical in the data. Read the −0.79% at CRMB with that in mind.
8. What this method cannot compute
First, no premium or discount. The snapshot holds only the price of the token and no reference price for the underlying. More decisively, dividends take a 30% US withholding deduction and are then reinvested through a multiplier — without the current multiplier, token unit price and share price are not comparable in the first place. No premium figure appears anywhere here.
Second, no shares per token. The snapshot carries no conversion ratio, so circulating supply converts into no claim at all.
Third, the windows behind range width are not equal. These five run 121 / 103 / 60 / 53 / 32 days; the shortest on the book is 5 days. Every book-wide width median quoted here is restricted to the 46 instruments listed 100 days or more — only ORCLB and PLTRB qualify (10th and 27th narrowest of the 46), and the widths of the other three (1.422x / 1.195x / 1.186x) cannot be compared against mature instruments.
Fourth, for an instrument listed under 30 days, the "30-day" field does not cover 30 days. Fifteen instruments on the book have been listed under 30 days and 11 under 20. The proof: APPB has been listed 5 days and its 7-day and 30-day fields are identical (−16.11% both), so the field is clipped to available history. All five here have at least 32 days, so their own 30-day figures are genuine 30 days; but the book median of −16.71% and every ranking quoted here include those 15 clipped values — five of which (LLYB, JPMB, BRKBB, UVXYB, TMFB) are positive and crowd the head of the ranking in section 3.
Fifth, market cap is the CMC definition: price times circulating supply. The book total of $1,318.38M here is the sum of these 100 rows, while the bStocks row on the /stocks page of this site shows an on-chain size of $914M — two numbers from different sources at different times, and they do not reconcile.
Sixth, 100 of 105. CMC reports 105 instruments; this snapshot holds 100. The missing 5 are in none of these figures.
Seventh, one chain. All 100 exist only on BNB Chain — no cross-chain liquidity fragmentation, and no redundancy either.
Conclusion. These five enterprise-software instruments hold $10.68M on bStocks, 0.8% of the book and 44% smaller than one S&P 500 ETF; at the same time all five rank in the best 27 on 30-day change, with a median of −2.02% against the book median of −16.71%, 14.69 points better. Both facts are true, but the second one has little to do with software.
The evidence is the ORCLB cohort: it ranks first of ten, and six of those ten are leveraged ETFs down between 22.36% and 78.03%, while the two other unleveraged common stocks in the same cohort, AXTIB and CRWVB, fell 31.51% and 38.18%. So the conclusion worth keeping is narrower: what this group shares is not an industry but a shape — a common-stock underlying, no leverage, and an underlying outside the eye of this particular storm. The instruments that actually made money this month were two −3x inverse ETFs, which have nothing to do with software and nothing to do with falling less.
The third point is turnover. The group at 0.6832x is indistinguishable from the other 95 at 0.6624x, and its market-cap share and volume share are both 0.8%. So do not read "small market cap" as "thinly traded": these five are traded normally for their size, and the spread inside the group — CRWDB 2.322x against CRMB 0.183x, a factor of 12.7 — is far larger than any gap between the group and the book.
Source CoinMarketCap, timestamped 2026-10-31T06:06:52Z, covering 100 of the 105 instruments bStocks reports. Instrument detail and quotes at /stocks/bstocks. This is research, not investment advice. DYOR.